name:-0.0011279582977295
name:-0.021197080612183
name:-0.0011320114135742
AutoImmune Inc. Patent Filings

AutoImmune Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for AutoImmune Inc..The latest application filed is for "treatment of multiple sclerosis using cop-1 and th2-enhancing cytokines".

Company Profile
0.20.1
  • AutoImmune Inc. - Pasadena CA
  • AutoImmune Inc. - Lexington MA
  • Autoimmune, Inc. -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Method of treating or preventing Type 1 diabetes by oral administration of insulin
Grant 6,703,361 - Weiner , et al. March 9, 2
2004-03-09
Bystander suppression of type I diabetes by oral administration of glucagon
Grant 6,645,504 - Weiner , et al. November 11, 2
2003-11-11
Treatment of multiple sclerosis using COP-1 and Th2-enhancing cytokines
App 20010007758 - Weiner, Howard L. ;   et al.
2001-07-12
Suppression of T-cell proliferation using peptide fragments of myelin basic protein
Grant 6,036,957 - Weiner , et al. March 14, 2
2000-03-14
Treatment of immune diseases by oral administration of autoantigens
Grant 5,869,093 - Weiner , et al. February 9, 1
1999-02-09
Treatment of multiple sclerosis by oral administration of autoantigens
Grant 5,869,054 - Weiner , et al. February 9, 1
1999-02-09
Peptide fragments of myelin basic protein
Grant 5,858,980 - Weiner , et al. January 12, 1
1999-01-12
Method of treating or preventing type 1 diabetes by oral administration of insulin
Grant 5,858,968 - Weiner , et al. January 12, 1
1999-01-12
Treatment of multiple sclerosis by oral administration of bovine myelin
Grant 5,849,298 - Weiner , et al. December 15, 1
1998-12-15
Method of treating or preventing Type 1 diabetes by oral administration of insulin
Grant 5,843,886 - Weiner , et al. December 1, 1
1998-12-01
Method for preparation of type II collagen
Grant 5,840,848 - Sturrock , et al. November 24, 1
1998-11-24
Methods and compositions for suppressing allograft rejection in mammals
Grant 5,788,968 - Weiner , et al. August 4, 1
1998-08-04
Method of treating or preventing type 1 diabetes by oral administration of insulin
Grant 5,763,396 - Weiner , et al. June 9, 1
1998-06-09
Treatment of autoimmune arthritis by oral administration of type I or type III collagen
Grant 5,733,547 - Weiner , et al. * March 31, 1
1998-03-31
Treatment of autoimmune diseases by aerosol administration of autoantigens
Grant 5,645,820 - Hafler , et al. July 8, 1
1997-07-08
Method of treating or preventing type 1 diabetes by oral administration of insulin
Grant 5,643,868 - Weiner , et al. July 1, 1
1997-07-01
Treatment of autoimmune diseases by aerosol administration of autoantigens
Grant 5,641,473 - Hafler , et al. June 24, 1
1997-06-24
Prevention of autoimmune diseases by aerosol administration of autoantigens
Grant 5,641,474 - Hafler , et al. June 24, 1
1997-06-24
Suppression of proliferative response and induction of tolerance with polymorphic class II MHC allopeptides
Grant 5,593,698 - Weiner , et al. January 14, 1
1997-01-14
Treatment of autoimmune diseases through administration by inhalation of autoantigens
Grant 5,571,500 - Hafler , et al. * November 5, 1
1996-11-05
Treatment of autoimmune diseases by aerosol administration of autoantigens
Grant 5,571,499 - Hafler , et al. November 5, 1
1996-11-05
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed